cyclophosphamide

Generic: cyclophosphamide

Labeler: baxter healthcare corporation
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cyclophosphamide
Generic Name cyclophosphamide
Labeler baxter healthcare corporation
Dosage Form INJECTION, POWDER, FOR SOLUTION
Routes
INTRAVENOUS ORAL
Active Ingredients

cyclophosphamide 1 g/50mL

Manufacturer
Baxter Healthcare Corporation

Identifiers & Regulatory

Product NDC 10019-956
Product ID 10019-956_2e97b53e-e39d-4190-9091-b8856a7cff7b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA040745
Listing Expiration 2026-12-31
Marketing Start 2008-05-21

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 10019956
Hyphenated Format 10019-956

Supplemental Identifiers

RxCUI
1734917 1734919 1734921
UNII
8N3DW7272P

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cyclophosphamide (source: ndc)
Generic Name cyclophosphamide (source: ndc)
Application Number ANDA040745 (source: ndc)
Routes
INTRAVENOUS ORAL
source: ndc

Resolved Composition

Strengths
  • 1 g/50mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-956-01) / 50 mL in 1 VIAL, SINGLE-DOSE (10019-956-16)
source: ndc

Packages (1)

Ingredients (1)

cyclophosphamide (1 g/50mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS", "ORAL"], "spl_id": "2e97b53e-e39d-4190-9091-b8856a7cff7b", "openfda": {"unii": ["8N3DW7272P"], "rxcui": ["1734917", "1734919", "1734921"], "spl_set_id": ["591d9955-3d9c-4cdc-a308-2f1288376b9f"], "manufacturer_name": ["Baxter Healthcare Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (10019-956-01)  / 50 mL in 1 VIAL, SINGLE-DOSE (10019-956-16)", "package_ndc": "10019-956-01", "marketing_start_date": "20080521"}], "brand_name": "Cyclophosphamide", "product_id": "10019-956_2e97b53e-e39d-4190-9091-b8856a7cff7b", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "product_ndc": "10019-956", "generic_name": "cyclophosphamide", "labeler_name": "Baxter Healthcare Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cyclophosphamide", "active_ingredients": [{"name": "CYCLOPHOSPHAMIDE", "strength": "1 g/50mL"}], "application_number": "ANDA040745", "marketing_category": "ANDA", "marketing_start_date": "20080521", "listing_expiration_date": "20261231"}